Ryan Specialty Holdings, Inc. (NYSE:RYAN) Given Average Recommendation of “Hold” by Analysts

Shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN) have earned a consensus rating of “Hold” from the nine brokerages that are presently covering the stock, MarketBeat.com reports. One investment analyst has rated the stock with a sell recommendation, four have issued a hold recommendation and four have assigned a buy recommendation to the company. The average 12 month price target among brokers that have covered the stock in the last year is $54.25.

A number of analysts have commented on the stock. Citigroup lifted their target price on shares of Ryan Specialty from $49.00 to $52.00 and gave the stock a “neutral” rating in a report on Wednesday, February 28th. JMP Securities reaffirmed a “market perform” rating on shares of Ryan Specialty in a research note on Monday. JPMorgan Chase & Co. boosted their price objective on shares of Ryan Specialty from $47.00 to $49.00 and gave the company an “underweight” rating in a report on Monday, April 8th. Wells Fargo & Company increased their target price on shares of Ryan Specialty from $57.00 to $58.00 and gave the stock an “overweight” rating in a report on Thursday, April 11th. Finally, Keefe, Bruyette & Woods boosted their price target on shares of Ryan Specialty from $56.00 to $62.00 and gave the company an “outperform” rating in a report on Wednesday, April 10th.

Ryan Specialty Trading Up 1.1 %

Shares of Ryan Specialty stock opened at $50.30 on Thursday. The company has a 50-day simple moving average of $51.24 and a 200 day simple moving average of $46.84. Ryan Specialty has a 12-month low of $39.44 and a 12-month high of $56.51. The company has a quick ratio of 1.16, a current ratio of 1.16 and a debt-to-equity ratio of 1.98. The stock has a market capitalization of $13.09 billion, a P/E ratio of 98.63 and a beta of 0.52.

Ryan Specialty (NYSE:RYAN) last issued its quarterly earnings results on Tuesday, February 27th. The company reported $0.35 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.35. The business had revenue of $532.90 million for the quarter, compared to analyst estimates of $524.08 million. Ryan Specialty had a return on equity of 44.84% and a net margin of 9.36%. The firm’s revenue for the quarter was up 22.5% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.27 earnings per share. Research analysts expect that Ryan Specialty will post 1.77 earnings per share for the current fiscal year.

Ryan Specialty Announces Dividend

The business also recently announced a None dividend, which was paid on Wednesday, March 27th. Investors of record on Wednesday, March 13th were paid a $0.34 dividend. The ex-dividend date of this dividend was Tuesday, March 12th. Ryan Specialty’s payout ratio is presently 86.27%.

Institutional Trading of Ryan Specialty

A number of institutional investors have recently modified their holdings of the company. Vanguard Group Inc. raised its stake in shares of Ryan Specialty by 2.2% during the 4th quarter. Vanguard Group Inc. now owns 9,397,569 shares of the company’s stock worth $404,283,000 after purchasing an additional 198,945 shares in the last quarter. BlackRock Inc. raised its holdings in Ryan Specialty by 13.7% in the 2nd quarter. BlackRock Inc. now owns 4,026,945 shares of the company’s stock valued at $180,770,000 after acquiring an additional 486,706 shares during the period. Blair William & Co. IL lifted its position in Ryan Specialty by 4.7% during the third quarter. Blair William & Co. IL now owns 2,650,891 shares of the company’s stock worth $128,303,000 after acquiring an additional 119,822 shares during the last quarter. Morgan Stanley boosted its holdings in shares of Ryan Specialty by 515.7% during the fourth quarter. Morgan Stanley now owns 2,467,647 shares of the company’s stock worth $102,432,000 after acquiring an additional 2,066,855 shares during the period. Finally, Price T Rowe Associates Inc. MD grew its position in shares of Ryan Specialty by 35.2% in the second quarter. Price T Rowe Associates Inc. MD now owns 2,072,078 shares of the company’s stock valued at $81,205,000 after purchasing an additional 539,003 shares during the last quarter. 84.82% of the stock is currently owned by institutional investors.

About Ryan Specialty

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.